BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
13. März 2024 07:00 ET
|
BioCardia, Inc.
BioCardia & StemCardia biotechnology company partnership targets heart failure, the leading cause of death and a condition with limited treatment options